BIP Q1 2026 Earnings Significant EPS Miss Sends Shares Lower AGNCN Q1 2026 Earnings Strong EPS Beat Driven by Stable Net Interest Spread Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline KEP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Cost Pressures Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues MTD Q1 2026 Earnings EPS Surpasses Estimates Despite Limited Revenue Disclosure